Search

Scott Dodds

Examiner (ID: 5800, Phone: (571)270-7653 , Office: P/1746 )

Most Active Art Unit
1746
Art Unit(s)
1791, 1746
Total Applications
996
Issued Applications
635
Pending Applications
97
Abandoned Applications
283

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7256019 [patent_doc_number] => 20040259801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Method for the synthesis of peptide salts, their use and pharmaceutical preparations containing the peptide salts' [patent_app_type] => new [patent_app_number] => 10/895468 [patent_app_country] => US [patent_app_date] => 2004-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1824 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259801.pdf [firstpage_image] =>[orig_patent_app_number] => 10895468 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/895468
Method for the synthesis of peptide salts, their use and pharmaceutical preparations containing the peptide salts Jul 12, 2004 Abandoned
Array ( [id] => 584656 [patent_doc_number] => 07438900 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-21 [patent_title] => 'Dendritic encapsulation of active agents' [patent_app_type] => utility [patent_app_number] => 10/885878 [patent_app_country] => US [patent_app_date] => 2004-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4549 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/438/07438900.pdf [firstpage_image] =>[orig_patent_app_number] => 10885878 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/885878
Dendritic encapsulation of active agents Jul 7, 2004 Issued
Array ( [id] => 5120511 [patent_doc_number] => 20070142226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Method and agents for improving plant productivity involving endophytic actinomycetes and metabolites thereof' [patent_app_type] => utility [patent_app_number] => 10/563637 [patent_app_country] => US [patent_app_date] => 2004-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 35363 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142226.pdf [firstpage_image] =>[orig_patent_app_number] => 10563637 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/563637
Method and agents for improving plant productivity involving endophytic actinomycetes and metabolites thereof Jul 6, 2004 Abandoned
Array ( [id] => 6972263 [patent_doc_number] => 20050037973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Compounds and methods for cancer therapy' [patent_app_type] => utility [patent_app_number] => 10/885482 [patent_app_country] => US [patent_app_date] => 2004-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 20018 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037973.pdf [firstpage_image] =>[orig_patent_app_number] => 10885482 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/885482
Compounds and methods for cancer therapy Jul 5, 2004 Abandoned
Array ( [id] => 7217980 [patent_doc_number] => 20050054818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Crystalline compositions for controlling blood glucose' [patent_app_type] => utility [patent_app_number] => 10/880884 [patent_app_country] => US [patent_app_date] => 2004-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12111 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054818.pdf [firstpage_image] =>[orig_patent_app_number] => 10880884 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/880884
Crystalline compositions for controlling blood glucose Jun 29, 2004 Abandoned
Array ( [id] => 7265310 [patent_doc_number] => 20040242846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Method for the preparation of molecularly uniform hyperpolymeric hemoglobins' [patent_app_type] => new [patent_app_number] => 10/878724 [patent_app_country] => US [patent_app_date] => 2004-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2780 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242846.pdf [firstpage_image] =>[orig_patent_app_number] => 10878724 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/878724
Method for the preparation of molecularly uniform hyperpolymeric hemoglobins Jun 27, 2004 Abandoned
Array ( [id] => 7264928 [patent_doc_number] => 20040242464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Non-pyrogenic, endotoxin-frei stroma-free tetrameric hemoglobin' [patent_app_type] => new [patent_app_number] => 10/876541 [patent_app_country] => US [patent_app_date] => 2004-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9792 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242464.pdf [firstpage_image] =>[orig_patent_app_number] => 10876541 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/876541
Non-pyrogenic, endotoxin-frei stroma-free tetrameric hemoglobin Jun 27, 2004 Abandoned
Array ( [id] => 7329787 [patent_doc_number] => 20040254115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator' [patent_app_type] => new [patent_app_number] => 10/865661 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14890 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254115.pdf [firstpage_image] =>[orig_patent_app_number] => 10865661 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/865661
Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator Jun 9, 2004 Issued
Array ( [id] => 7319591 [patent_doc_number] => 20040225120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Process for purifying a compound' [patent_app_type] => new [patent_app_number] => 10/863456 [patent_app_country] => US [patent_app_date] => 2004-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10753 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20040225120.pdf [firstpage_image] =>[orig_patent_app_number] => 10863456 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/863456
Process for purifying a compound Jun 7, 2004 Issued
Array ( [id] => 263776 [patent_doc_number] => 07569541 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-04 [patent_title] => 'Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines' [patent_app_type] => utility [patent_app_number] => 10/559010 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7656 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/569/07569541.pdf [firstpage_image] =>[orig_patent_app_number] => 10559010 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/559010
Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines Jun 1, 2004 Issued
Array ( [id] => 4999826 [patent_doc_number] => 20070042460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Oxidation of peptides' [patent_app_type] => utility [patent_app_number] => 10/558958 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1592 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20070042460.pdf [firstpage_image] =>[orig_patent_app_number] => 10558958 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/558958
Oxidation of peptides May 27, 2004 Abandoned
Array ( [id] => 7297174 [patent_doc_number] => 20040214747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Method for administering monomeric insulin' [patent_app_type] => new [patent_app_number] => 10/852568 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7334 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214747.pdf [firstpage_image] =>[orig_patent_app_number] => 10852568 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/852568
Method for administering monomeric insulin May 23, 2004 Abandoned
Array ( [id] => 7297232 [patent_doc_number] => 20040214781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Pharmaceutical composition containing pGLU-GLU-PRO-NH2 and method for treating diseases and injuries to the brain, spinal cord and retina using same' [patent_app_type] => new [patent_app_number] => 10/851617 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5719 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214781.pdf [firstpage_image] =>[orig_patent_app_number] => 10851617 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/851617
Pharmaceutical composition containing pGLU-GLU-PRO-NH2 and method for treating diseases and injuries to the brain, spinal cord and retina using same May 20, 2004 Abandoned
Array ( [id] => 582632 [patent_doc_number] => 07449443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-11 [patent_title] => 'Method for stabilization of proteins using non-natural amino acids' [patent_app_type] => utility [patent_app_number] => 10/851564 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10309 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/449/07449443.pdf [firstpage_image] =>[orig_patent_app_number] => 10851564 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/851564
Method for stabilization of proteins using non-natural amino acids May 20, 2004 Issued
Array ( [id] => 7083797 [patent_doc_number] => 20050049177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Stable analogs of peptide and polypeptide therapeutics' [patent_app_type] => utility [patent_app_number] => 10/847220 [patent_app_country] => US [patent_app_date] => 2004-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 20931 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20050049177.pdf [firstpage_image] =>[orig_patent_app_number] => 10847220 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/847220
Stable analogs of peptide and polypeptide therapeutics May 16, 2004 Issued
Array ( [id] => 5259886 [patent_doc_number] => 20070213518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Novel Lipolytic Enzyme Lip2' [patent_app_type] => utility [patent_app_number] => 10/555560 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14347 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213518.pdf [firstpage_image] =>[orig_patent_app_number] => 10555560 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/555560
Novel Lipolytic Enzyme Lip2 May 11, 2004 Abandoned
Array ( [id] => 7441635 [patent_doc_number] => 20040185539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Process for the preparation of 2-hydroxymethyl-pyrolidine 3, 4-diols' [patent_app_type] => new [patent_app_number] => 10/472042 [patent_app_country] => US [patent_app_date] => 2004-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4611 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20040185539.pdf [firstpage_image] =>[orig_patent_app_number] => 10472042 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/472042
Process for the preparation of 2-hydroxymethyl-pyrolidine 3, 4-diols May 3, 2004 Abandoned
Array ( [id] => 7038939 [patent_doc_number] => 20050158373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Method and carrier complexes for delivering molecules to cells' [patent_app_type] => utility [patent_app_number] => 10/838135 [patent_app_country] => US [patent_app_date] => 2004-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17255 [patent_no_of_claims] => 123 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158373.pdf [firstpage_image] =>[orig_patent_app_number] => 10838135 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/838135
Method and carrier complexes for delivering molecules to cells May 2, 2004 Issued
Array ( [id] => 4927883 [patent_doc_number] => 20080167246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'Ophthalmic and Contact Lens Solutions Containing Peptides as Preservative' [patent_app_type] => utility [patent_app_number] => 10/593352 [patent_app_country] => US [patent_app_date] => 2004-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3305 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20080167246.pdf [firstpage_image] =>[orig_patent_app_number] => 10593352 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/593352
Ophthalmic and contact lens solutions containing peptides as preservative Apr 14, 2004 Issued
Array ( [id] => 4872688 [patent_doc_number] => 20080199422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Method for the Treatment of Myelodysplastic Syndromes Using 1-Oxo-2-(2,6-Dioxopiperidin-3-Yl-)-4-Methylisoindoline' [patent_app_type] => utility [patent_app_number] => 11/547926 [patent_app_country] => US [patent_app_date] => 2004-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18069 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20080199422.pdf [firstpage_image] =>[orig_patent_app_number] => 11547926 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/547926
Method for the Treatment of Myelodysplastic Syndromes Using 1-Oxo-2-(2,6-Dioxopiperidin-3-Yl-)-4-Methylisoindoline Apr 13, 2004 Abandoned
Menu